Genomic Solutions, Harvard Bio deal

HBIO completed its previously announced acquisition of GNSL, paying 0.1017 shares plus $0.2861 in cash for each GNSL share (see BioCentury, July 22). GNSL will operate as a wholly owned subsidiary of ...